Skip to Accessibility Tools Skip to Content Skip to Footer

New Clinical Practice Guidelines for Alpha-1

New clinical practice guidelines were published and released this week regarding the diagnosis and treatment of Alpha-1. These new guidelines are an update to the 2003 version.

The individuals who were involved in the creation of these new guidelines were: The clinical director of the Alpha-1 Foundation, a researcher and former president of the American Thoracic Society, several leading Alpha-1 experts, a bioethicist and a medical librarian.

What is most noteworthy is that the new guidelines are recommending that “anyone with chronic obstructive pulmonary disease (COPD) should be tested for Alpha-1, regardless of age or ethnicity.”

You may be wondering what are “clinical practice guidelines”? Clinical practice guidelines make recommendations for best practice in diagnosis, treatment and management of a disease or condition using the most current research and scientific evidence available. These guidelines assist healthcare providers in providing the best, up-to-date care for their patients.

For more information on these guidelines, see the Alpha-1 website.

This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.

  1. Sandhaus, R. A., Turino, G., Brantly, M. L., Cross, C. E., Campos, M., Goodman, K., ... & Strange, C. The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult. Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, 3(3), In-press.
  2. Foundation, A.-. (2016). Clinical Practice Guidelines published to help physicians identify and treat Alpha-1 Antitrypsin Deficiency in adults. Newly Diagnosed/Top Stories. Retrieved from